Pulmonx Corp

LUNG · XNAS

CIK 1127537fmd_09WEFQ5222MZKFEVWCFZS81R40Manufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Jan 01, 2018 to Sep 30, 2026, 32 periods

Income Statement · Annual · Millions · USD
Line item	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Total revenues	20	33	33	48	54	69	84	90
Cost of revenue	8	10	12	13	14	18	22	23
Gross profit	12	22	21	36	40	51	62	67
Research and development	7	6	7	13	15	18	18	19
Selling, general and administrative	20	34	46	70	83	95	102	101
Total operating expenses	27	40	54	83	99	113	120	121
Operating income	(15)	(18)	(32)	(47)	(59)	(62)	(58)	(54)
Interest expense	3	2	3	1	1	3	4	3
Interest and investment income	0	0	0	0	2	6	5	3
Other non-operating income (expense)	(1)	(1)	3	(1)	(0)	(1)	0	1
Income before taxes	(18)	(20)	(32)	(48)	(59)	(60)	(56)	(53)
Income tax expense	0	0	0	0	0	1	1	1
Net income from continuing operations	(18)	(21)	(32)	(49)	(59)	(61)	(56)	(54)
Net income	(18)	(21)	(32)	(49)	(59)	(61)	(56)	(54)
Net income to common shareholders	(18)	(21)	(32)	(49)	(59)	(61)	(56)	(54)